VisusNano
1 known investors
VisusNano develops drug-eluting intraocular lens implants for cataract surgery patients, designed to reduce postoperative complications including infection, inflammation, and cell proliferation. The biodegradable polymer-based system delivers medications directly at the implant site, eliminating the need for postoperative eye drops or laser treatment in both human and veterinary markets.
BiotechHealthtechMedical Devices